Patents

US 10369223 B2: Single domain antibodies directed against ebola virus VP24

Granted
2019-08-06
Filed
2016-11-02 application 15342044
Type
Utility · 2 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This invention provides compositions and methods to treat a condition or disease without the use of exogenous targeting sequences or chemical compositions. The present invention relates to single-domain antibodies (sdAbs), proteins and polypeptides comprising the sdAbs that are directed against targets that cause a condition or disease. The invention also includes nucleic acids encoding the sdAbs, proteins and polypeptides, and compositions comprising the sdAbs. The invention includes the use of the compositions, sdAbs, and nucleic acids encoding the sdAbs for prophylactic, therapeutic or diagnostic purposes.

Source: PVGPATDIS, file of 2026-04-10 (ipg190806.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Singh Biotechnology, LLC 4 patentsUS company or organizationHudson, FLSINGH BIOTECHNOLOGY, LLC State business registration EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Sunanda SinghLutz, FL10PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K45/06PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K16/104PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/12PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N2760/14111PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y113/11031PVGPATDIS, file of 2026-04-10
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/56983PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-12-07Name change
Notice of assignee's change of address
SINGH BIOTECHNOLOGY, LLC signed 2021-12-07SINGH BIOTECHNOLOGY, LLC LUTZ, FL58348/135ECORSEXC, file of 2026-09-25
2018-07-05Assignment
Assignment of assignor's interest
SINGH, SUNANDA, M.D. signed 2018-06-20SINGH BIOTECHNOLOGY, LLC HUDSON, FL46270/868ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.